Dewan B, Navale S, Shah D. A novel thromboxane A2 receptor inhibitor, seratrodast shows greater improvement in peak expiratory flow, expectoration score, sputum eosinophil cationic protein and albumin levels as compared to montelukast in a double-blind comparative clinical trial. Respirology. 2014;19(suppl. 3);O-A-005.